Poland - Pharmaceutical products
For more information and to make a bid you will need to go to the third party website.
Details
Provided by
- Opportunity closing date
- 24 April 2019
- Opportunity publication date
- 19 March 2019
- Category
- 33600000, , , , , , , , , , , ,
- Value of contract
- to be confirmed
- Your guide to exporting
Description
1 Acetylcysteinum 200 mg tab.mus. sparkling table 2 000,002 Acetylcysteinum 100 mg /1 ml and 3 ml ampoule 175,003 Ambroxol hydrochloride 15 mg ampoule 100,004 Amlodipine 10 mg tabl/cap 1 050,005 Amlodipine 5 mg tabl/cap 3 000,006 Dobutamine 250 mg vial 300,007 Ketoprofenum 100 mg/2 ml. i.v. i.m. ampoule 700,008 Ketoprofen 100 mg tabl/cap 600,009 Ketoprofenum 50 mg tabl/cap 600,00 1 Acidum tannicum substance (tannin) g 200,002 Ammonia bromidum substance g 500,003 Benzocainum substance g 100,004 Bismuthum subgalicum substance g 200,005 Ethanolum 70 % 500 ml container 10,006 Kalium bromidum substance g 500,007 Natrium bromatum substrate g 500,008 Natrium tetraboricum substance g 200,009 Oleum Methae 10ml bottle 1,0010 Hydrogenium peroxydatum 3 % x 100g packaging 5,00 1 Eucerine substance 1 kg packaging 10,002 Glycerol 86 % liquid 1 kg packaging 10,003 Glucose substance 1000 g packaging 25,004 Vaselinum album substance 1 kg packaging 15,005 Lanolin substance 500 g packaging 10,006 Magnesii hydroaspartas 17 mg Mg +Kalii hydroaspartas 54 mg K. Table 1 500,00 1 Specialty amino acids used in impaired liver function 500 ml bottle 5,002 Specialty amino acids used in impaired kidney function 500 ml bottle 5,003 Trace element water solution, a 10 ml bottle 300,004 Glutamine solution for infusions concentrate 50 ml bottle 60,005 Glutamine solution for infusions concentrate 100 ml bottle 180,006 Organic phosphate preparation (Anhydrous sodium glycerolphosphate 216 mg Ph.Fr a 20 ml bottle 140.007 Powder for preparation of r-ru vitamins rozp. in water for adults. a 10 ml bottle 200.008 Solution of vitamins rozp. in fats for adults. a 10 ml bottle 200,009 Mannitol 20 % inj 100 ml (glass bottle) bottle 200,0010 Mannitol 20 % inj 250 ml (glass bottle) bottle bottle 10,0011 Powder for solution for injection and infusion containing vitamins soluble in solution. aqueous and fatty acids except vit K(adult) vial 150.0012 Sterile irrigation water 1000 ml (screw-on bottle) bottle 420.0013 kalium chlorine 15 % ampoule in needle-free system and 10 ml ampoule 400.0014 Flumazenil, injection solution 0.5 mg/5 ml ampoule 15.0015 Complete high-energy diet, enriched with branched, low sodium amino acids. Contains no gluten, clinically lactose free.200 ml bottle 48.0016 Three-chamber bag without electrolytes 986 ml for central parenteral feeding containing a solution of amino acids with taurine, glucose and zinc, LCT fats, MCT, olive oil, omega-3 fatty acids, 8 g of nitrogen, 900 kcal of non-protein energy, 1300 mosmol/l osmolality. 98.90 net + 8%VAT/bag 8.0017 Three-chamber bag without electrolytes 1477 ml for central parenteral feeding containing a solution of amino acids with taurine, glucose with zinc, LCT fats, MCT, olive oil, omega-3 fatty acids, with a nitrogen content of 12 g, non-protein energy 1300 kcal, osmolality 1300 mosmol/l. 24,0018 Three-chamber central injection bag with a capacity of up to 500 ml, containing min 4gN, containing a mixture of 4 types of fat emulsions including fish oil 14-15 %, soybean oil, MCT, olive oil, electrolytes, carbohydrates. Osmolarity 1500 mOsm/l 24.0019 three-chamber bag for peripheral and central parenteral feeding up to 1250 ml. Minimum content of N 6,2 g containing a mixture of 4 types of fat emulsions including fish oil 14-15 %, soybean oil, MCT, olive oil, electrolytes, carbohydrates. Osmolarity 850 mOsm/l bag 20,00. 1 Insulin aspart 100 jm/ml 3ml - NovoRapid Penfil cartridge 200,002 Insulin lispro 100 jm/ml,3ml - Humalog cartridge 10,003 Insulin injection neutral Insulin human 100 jm/ml x 10 ml Gensulin R x 1 vial 5,004 Insulin injection neutral Insulin human 300 jm/3 ml - Gensulin R cartridge 80,005 Insulin injection neutral, Insulin human 100 jm/ml, 3 ml- Actrapid HM input 30,006 Insulin injection neutral, Insulin human 100jm/ml 3 ml- Humulin R input 10,007 Insulin human isophane 100jm/ml,3 ml - Gensulin N input 10,008 Insulin human isophane 100 IU/ml,3 ml) - Humulin N cartridge 10,009 Insulin human isophane 100 IU/ml, 3 ml - Insulatard HM cartridge 100,0010 Insulin Aspart/aspart protamine suspension 100 IU/ml, 3 ml - NovoMix 30 cartridge 40,0011 Insulin aspart/aspart protamine suspension 100 IU/ml, 3 ml - NovoMix 50 cartridge 20.0012 Insulin lispro/lispo protamine suspensione 100 jm/ml, 3 ml- HumalogMix 25 cartridge 20.0013 Insulin lispro/lispo protamine suspensione 100 jm/ml, 3 ml- HumalogMix 50 cartridge 20.0014 Insulin biphasic injection (ins.human neutral+isophane suspension)100jm/ml 3ml (30/70) - GensulinM30 cartridge 30,0015 Insulin biphasic injection (ins.human neutral/isophane suspension) 100 jm/ml, 3 ml (50/50) - GensulinM50 x 5 cartridge 20,0016 Insulin biphasicinjection (ins.human neutral/isophane suspension) 100 jm/ml 3 ml (30/70) - Humulin M3 cartridge 10,0017 Ins.biphasic injection(ins human neutral/isophane suspension)100 jm/ml, 3 ml - Mixtard 30 cartridge 60,0018 Ins.biphasic injection(ins human neutral/isophane suspension)100 jm/ml, 3 ml - Mixtard 50 cartridge 10,0019 Ins Lisipro liprolog 100 jm/ml and 3 ml cartridge 40,0020 Insulin determir 100 jm/ml 3 ml - Insul. Levemir cartridge 5.00 1 sodium Ibandrate 1 mg/l ml pre-filled syringe 3 ml pre-filled syringe 90.00 1 Glycemic normalizing diet, for use in diabetes, impaired glucose tolerance. nutritionally complete, containing dietary fiber 1.5-2g/100 ml for gastrointestinal nutrition treatment. Clinically lactose free, gluten-free. Content of monounsaturated fatty acids min 2,9 g/100 ml. Composition allowing to obtain energy from protein 17-18 %, carbohydrates 37-45 %, fat 35-45 % Osmolarity up to 300 mOsm/l.+/_50.Pack 1000 ml pack 48.002 Complete, high-calorie diet (1.5 kcal/ml), residue-free, for digestive tract nutritional treatment. The main source of protein should be casein, whey, soya, peas. Clinically free of lactose, gluten-free, contains MCT fats, fish fat, fibre-free, diet enriched with DHA/EPA acids. Iron content min 2.0.Energy from protein 16-20 %, carbohydrates-45-49, fat approx. 35%/+/-5. Osmolarity up to 370 mOsm/l.+/_50.500 ml bottle type packaging 48.003 Complete, normal calorie, residue-free diet for digestive tract nutritional treatment. The main source of protein should be casein, whey, soya, peas Clinically lactose-free, gluten-free.Diet should contain MCT fat. It should be enriched with DHA/EPA acids. Energy obtained from protein 16 %, carbohydrates 49 %, fat 35 %. Osmolality 255 mOsm/l +/_50 500 ml bottle type packaging 48.004 Complete, hypercaloric diet (1.28 kcal/ml, high protein with arginine, residue-free, in the form of a beverage, for digestive tract nutritional treatment, gluten-free, low-lactose. The protein source is sewate, casein, low fat content, contains mainly LCT fat. Increased content of ingredients needed in the treatment of ran-vit C, carotenoids, vit E and Zn. Package 200 ml pack 48.005 Complete, high energy diet (min 1.6 kcal/ml, high protein min 9g/100 ml, low glycemic index Osmolarity max 300 mOsm/l .For oral administration.Package size 200 ml. Fruit or vanilla flavour at the customer's choice 48.00 1 Vaccine against measles, mgr+ Elbasvir 50 mg opk 602 Rybavirin 200 mg packaged in blister max 140 tabl. and reimbursed by the National Health Fund in the treatment regimen from item 1 400 1 Entecavir tabl 0.5 mg opk 100 1 Interferon pegylated alpha 2a pen (135 or 180 mcg) mcg 129602 Rybavirin tabl 200 mg reimbursed by the National Health Fund in the treatment regimen from item 1 opk 20
- Opportunity closing date
- 24 April 2019
- Value of contract
- to be confirmed
About the buyer
- Address
- Uniwersyteckie Centrum Medycyny Morskiej i Tropikalnej ul. Powstania Styczniowego 9b Gdynia 81-519 Poland
- Contact
- dzp@ucmmit.gdynia.pl
The deadline to apply for this opportunity has passed.
Visit the
opportunities page
to find another.